Annual EPS
-$34.01
-$2.86-9.18%
December 31, 2023
Summary
- As of February 7, 2025, BBLG annual earnings per share is -$34.01, with the most recent change of -$2.86 (-9.18%) on December 31, 2023.
- During the last 3 years, BBLG annual EPS has risen by +$117.19 (+77.51%).
- BBLG annual EPS is now -9.18% below its all-time high of -$31.15, reached on December 31, 2022.
Performance
BBLG EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$2.37
-$1.70-253.73%
September 30, 2024
Summary
- As of February 7, 2025, BBLG quarterly earnings per share is -$2.37, with the most recent change of -$1.70 (-253.73%) on September 30, 2024.
- Over the past year, BBLG quarterly EPS has dropped by -$1.70 (-253.73%).
- BBLG quarterly EPS is now -101.58% below its all-time high of $150.00, reached on June 30, 2017.
Performance
BBLG Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$7.25
+$2.53+25.87%
September 30, 2024
Summary
- As of February 7, 2025, BBLG TTM earnings per share is -$7.25, with the most recent change of +$2.53 (+25.87%) on September 30, 2024.
- Over the past year, BBLG TTM EPS has increased by +$2.53 (+25.87%).
- BBLG TTM EPS is now at all-time high.
Performance
BBLG TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
BBLG EPS Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -9.2% | -253.7% | +25.9% |
3 y3 years | +77.5% | +54.5% | +88.8% |
5 y5 years | +93.6% | +54.5% | +88.8% |
BBLG EPS Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -9.2% | +59.5% | -109.9% | +95.7% | at high | +94.0% |
5 y | 5-year | -9.2% | +87.9% | -109.9% | +95.7% | at high | +97.4% |
alltime | all time | -9.2% | +99.2% | -101.6% | +99.8% | at high | +99.8% |
Bone Biologics EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.37(+253.7%) | -$7.25(-25.9%) |
Jun 2024 | - | -$0.67(-48.9%) | -$9.78(-31.7%) |
Mar 2024 | - | -$1.31(-54.8%) | -$14.32(-79.0%) |
Dec 2023 | -$34.01(+9.2%) | -$2.90(-40.8%) | -$68.21(+65.0%) |
Sep 2023 | - | -$4.90(-6.0%) | -$41.34(-36.1%) |
Jun 2023 | - | -$5.21(-90.6%) | -$64.68(-8.1%) |
Mar 2023 | - | -$55.20(-330.3%) | -$70.35(+120.2%) |
Dec 2022 | -$31.15(-62.9%) | $23.97(-184.9%) | -$31.95(-46.8%) |
Sep 2022 | - | -$28.24(+159.6%) | -$60.04(-17.3%) |
Jun 2022 | - | -$10.88(-35.2%) | -$72.60(-29.2%) |
Mar 2022 | - | -$16.80(+307.6%) | -$102.52(-15.8%) |
Dec 2021 | -$84.00(-44.4%) | -$4.12(-89.9%) | -$121.72(-22.0%) |
Sep 2021 | - | -$40.80(0.0%) | -$156.00(+4.8%) |
Jun 2021 | - | -$40.80(+13.3%) | -$148.80(+7.8%) |
Mar 2021 | - | -$36.00(-6.3%) | -$138.00(-8.0%) |
Dec 2020 | -$151.20(-46.4%) | -$38.40(+14.3%) | -$150.00(-2.3%) |
Sep 2020 | - | -$33.60(+12.0%) | -$153.60(-8.6%) |
Jun 2020 | - | -$30.00(-37.5%) | -$168.00(-22.2%) |
Mar 2020 | - | -$48.00(+14.3%) | -$216.00(-23.4%) |
Dec 2019 | -$282.00 | -$42.00(-12.5%) | -$282.00(-35.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | -$48.00(-38.5%) | -$438.00(+7.4%) |
Jun 2019 | - | -$78.00(-31.6%) | -$408.00(-19.0%) |
Mar 2019 | - | -$114.00(-42.4%) | -$504.00(-14.3%) |
Dec 2018 | -$528.00(-51.4%) | -$198.00(+1000.0%) | -$588.00(-27.9%) |
Sep 2018 | - | -$18.00(-89.7%) | -$816.00(-29.9%) |
Jun 2018 | - | -$174.00(-12.1%) | -$1164.00(+38.6%) |
Mar 2018 | - | -$198.00(-53.5%) | -$840.00(-25.1%) |
Dec 2017 | -$1086.00(-73.8%) | -$426.00(+16.4%) | -$1122.00(-50.3%) |
Sep 2017 | - | -$366.00(-344.0%) | -$2256.00(-11.5%) |
Jun 2017 | - | $150.00(-131.3%) | -$2550.00(-26.7%) |
Mar 2017 | - | -$480.00(-69.2%) | -$3480.00(-17.3%) |
Dec 2016 | -$4140.00(+40.8%) | -$1560.00(+136.4%) | -$4207.04(+1.8%) |
Sep 2016 | - | -$660.00(-15.4%) | -$4133.87(+0.8%) |
Jun 2016 | - | -$780.00(-35.4%) | -$4100.36(+17.6%) |
Mar 2016 | - | -$1207.04(-18.8%) | -$3486.31(+34.9%) |
Dec 2015 | -$2940.00(+256.7%) | -$1486.83(+137.3%) | -$2585.12(+135.4%) |
Sep 2015 | - | -$626.49(+277.5%) | -$1098.29(+132.8%) |
Jun 2015 | - | -$165.95(-45.7%) | -$471.80(+54.3%) |
Mar 2015 | - | -$305.85 | -$305.85 |
Dec 2014 | -$824.22 | - | - |
FAQ
- What is Bone Biologics annual earnings per share?
- What is the all time high annual EPS for Bone Biologics?
- What is Bone Biologics annual EPS year-on-year change?
- What is Bone Biologics quarterly earnings per share?
- What is the all time high quarterly EPS for Bone Biologics?
- What is Bone Biologics quarterly EPS year-on-year change?
- What is Bone Biologics TTM earnings per share?
- What is the all time high TTM EPS for Bone Biologics?
- What is Bone Biologics TTM EPS year-on-year change?
What is Bone Biologics annual earnings per share?
The current annual EPS of BBLG is -$34.01
What is the all time high annual EPS for Bone Biologics?
Bone Biologics all-time high annual earnings per share is -$31.15
What is Bone Biologics annual EPS year-on-year change?
Over the past year, BBLG annual earnings per share has changed by -$2.86 (-9.18%)
What is Bone Biologics quarterly earnings per share?
The current quarterly EPS of BBLG is -$2.37
What is the all time high quarterly EPS for Bone Biologics?
Bone Biologics all-time high quarterly earnings per share is $150.00
What is Bone Biologics quarterly EPS year-on-year change?
Over the past year, BBLG quarterly earnings per share has changed by -$1.70 (-253.73%)
What is Bone Biologics TTM earnings per share?
The current TTM EPS of BBLG is -$7.25
What is the all time high TTM EPS for Bone Biologics?
Bone Biologics all-time high TTM earnings per share is -$7.25
What is Bone Biologics TTM EPS year-on-year change?
Over the past year, BBLG TTM earnings per share has changed by +$2.53 (+25.87%)